ICMR Liberalises Import Of Testing Kits, Allows Globally Approved Tests In India
New Delhi : The Drugs Controller General of India will accord marketing permission in India on the basis of their existing approvals, Balram Bhargava, secretary, department of health research and director…
Parameters for evaluating FDCs should be changed: IDMA
The Sub-committee of Drugs Technical and Advisory Board (DTAB) is examining the fixed-dose combinations (FDCs) which are considered irrational by Prof Kokate Committee. The committee has asked the concerned applicants to…
NPPA & ICMR together will check usage of Cocktail drugs
NPPA & ICMR together will check usage of Cocktail drugs New Delhi: The Modi government plans to increase monitoring of the usage of cocktail drugs in the country. To that end, the drug…
Govt Job as Additional Director General at ICMR
Indian Council of Medical Research (ICMR) is an Autonomous Organization under the Department of Health Research, Ministry of Health & Family Welfare, Govt, of India. ICMR is dealing with biomedical / health…
Govt Job for the post of Scientist at AIIMS
All-India Institute of Medical Sciences was established as an institution of national importance by an Act of Parliament with the objects to develop patterns of teaching in Undergraduate and Post-graduate Medical…
Govt Job for MD, MS, DNB, Ph.D for Scientific Position in ICMR
Indian Council of Medical Research (ICMR) is an Autonomous Organization under the Department of Health Research, Ministry of Health & Family Welfare, Govt, of India. ICMR is dealing with biomedical / health…
Zydus Cadila seeks approval to begin phase III trials of COVID-19 vaccine ZyCoV-D
Zydus Cadila, an innovation driven global pharmaceutical company focused on discovering and developing NCEs, novel biologicals, biosimilars and vaccines, announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D was…
AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin
The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday invited volunteers for the Phase III clinical trial of the indigenously developed Covid-19 vaccine candidate ‘Covaxin’ for which…
DCGI Seeking More Data For Granting Emergency Use Authorisation Won’t Impact Timeline For Vaccine Roll-Out: Govt
New Delhi : The applications of Bharat Biotech, Serum Institute and Pfizer seeking emergency use authorisation for their COVID-19 vaccines are being examined, the Centre said on Tuesday asserting that drug…
Covaxin may be launched in February 2021: ICMR
Bharat Biotech may launch COVAXIN as early as February – months earlier than expected – as last-stage trials begin this month and studies have so far shown it is safe and effective, a…
